| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 121.303.727 $ | 100,33 | 3.488.534 | |||||||
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 6.142.898 $ | 5,08 | 19.267 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 5.623.234 $ | 4,65 | 197.099 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 4.152.572 $ | 3,43 | 7.268 | |
| Tenet Healthcare Corp. | Tenet Healthcare Corp. | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 3.674.354 $ | 3,04 | 20.745 | |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 3.459.928 $ | 2,86 | 65.368 | |
| Tango Therapeutics Inc. | Tango Therapeutics Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 3.448.174 $ | 2,85 | 159.490 | |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 3.357.430 $ | 2,78 | 7.728 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 3.196.234 $ | 2,64 | 15.385 | |
| Nektar Therapeutics | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 3.109.913 $ | 2,57 | 36.570 | |
| Celcuity Inc. | Celcuity Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 3.055.836 $ | 2,53 | 25.182 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 2.870.335 $ | 2,37 | 38.394 | |
| Capricor Therapeutics, Inc. | Capricor Therapeutics, Inc. | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 2.733.479 $ | 2,26 | 81.402 | |
| Cencora, Inc. | Cencora, Inc. | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 2.719.420 $ | 2,25 | 8.829 | |
| Alumis Inc. | Alumis Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 2.564.600 $ | 2,12 | 103.872 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 2.402.615 $ | 1,99 | 18.363 | |
| Kodiak Sciences Inc. | Kodiak Sciences Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 2.401.096 $ | 1,99 | 55.223 | |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 2.390.105 $ | 1,98 | 49.825 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 2.319.707 $ | 1,92 | 11.426 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 2.300.675 $ | 1,90 | 50.080 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 2.292.640 $ | 1,90 | 23.165 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 2.271.000 $ | 1,88 | 152.008 | |
| Dianthus Therapeutics, Inc. | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 2.170.943 $ | 1,80 | 24.726 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 2.149.897 $ | 1,78 | 32.708 | |
| Ensign Group, Inc. (The) | Ensign Group, Inc. (The) | EC | 29358P101 | Long | Börsenkurs (Stufe 1) | 2.095.222 $ | 1,73 | 11.223 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 2.073.361 $ | 1,71 | 21.763 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 2.067.122 $ | 1,71 | 194.096 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 1.954.914 $ | 1,62 | 8.520 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 1.937.576 $ | 1,60 | 28.323 | |
| CG Oncology, Inc. | CG Oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 1.876.395 $ | 1,55 | 28.115 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 1.862.287 $ | 1,54 | 53.591 | |
| SELLAS Life Sciences Group, Inc. | SELLAS Life Sciences Group, Inc. | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 1.817.719 $ | 1,50 | 367.216 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 1.795.734 $ | 1,49 | 24.120 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 1.770.163 $ | 1,46 | 21.835 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 1.757.241 $ | 1,45 | 30.064 | |
| Liquidia Corp. | Liquidia Corp. | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 1.712.418 $ | 1,42 | 43.673 | |
| Brookdale Senior Living Inc. | Brookdale Senior Living Inc. | EC | 112463104 | Long | Börsenkurs (Stufe 1) | 1.707.734 $ | 1,41 | 118.923 | |
| Axogen, Inc. | Axogen, Inc. | EC | 05463X106 | Long | Börsenkurs (Stufe 1) | 1.654.992 $ | 1,37 | 38.310 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 1.611.719 $ | 1,33 | 36.251 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 1.585.431 $ | 1,31 | 51.209 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 1.570.209 $ | 1,30 | 114.114 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 1.436.702 $ | 1,19 | 22.459 | |
| Elanco Animal Health Inc. | Elanco Animal Health Inc. | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 1.408.214 $ | 1,16 | 62.951 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 1.368.239 $ | 1,13 | 105.574 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 1.357.633 $ | 1,12 | 77.358 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 1.354.470 $ | 1,12 | 23.663 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 1.330.445 $ | 1,10 | 5.073 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 1.292.272 $ | 1,07 | 31.343 | |
| Arcus Biosciences, Inc. | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 1.139.468 $ | 0,94 | 44.685 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 1.109.025 $ | 0,92 | 188.931 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 1.103.155 $ | 0,91 | 33.715 | |
| Phibro Animal Health Corp. | Phibro Animal Health Corp., Class A | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 1.092.583 $ | 0,90 | 20.545 | |
| MoonLake Immunotherapeutics | MoonLake Immunotherapeutics | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 951.531 $ | 0,79 | 58.091 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 932.597 $ | 0,77 | 55.347 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 878.909 $ | 0,73 | 41.013 | |
| Perspective Therapeutics Inc. | Perspective Therapeutics Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 809.137 $ | 0,67 | 207.471 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 766.637 $ | 0,63 | 39.681 | |
| Viridian Therapeutics, Inc. | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 702.295 $ | 0,58 | 52.099 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 613.094 $ | 0,51 | 23.066 | |
| 121.303.727 $ | 100,33 | 3.488.534 |